Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

INTRODUCTION: Some myasthenia gravis (MG) patients are refractory to conventional treatments. METHODS: To describe the clinical features of refractory MG (RMG) and explore the association with human leukocyte antigen HLA-DRB1 alleles, a cohort study of 114 consecutive MG patients was performed. Patients were classified as RMG based on predefined criteria. RESULTS: Twenty-two patients were found to have RMG (19.3%). There were no differences between non-RMG and RMG patients with respect to sex, age of onset, abnormal 3-Hz repetitive nerve stimulation, anti-acetylcholine receptor antibody positivity, thymectomy, thymoma or thymic hyperplasia, and polyautoimmunity. HLA-DRB1*03 was more frequent in the non-RMG vs. control population (P = 3 × 10-6 ). The HLA-DRB1*13 allele was less frequent in non-RMG patients compared with controls (P = 0.002), and less frequent in the non-RMG group compared with the RMG group (P = 0.003). DISCUSSION: HLA-DRB1*03 was more common in non-RMG, and the HLA-DRB1*13 allele appeared to have a protective role, as reported previously in other autoimmune disorders. Muscle Nerve 60: 188-191, 2019.

Original publication

DOI

10.1002/mus.26507

Type

Journal article

Journal

Muscle Nerve

Publication Date

08/2019

Volume

60

Pages

188 - 191

Keywords

human leukocyte antigens, myasthenia gravis, polyautoimmunity, refractory, thymoma MG, Adult, Age of Onset, Autoantibodies, Case-Control Studies, Cohort Studies, Female, Genetic Predisposition to Disease, HLA-DRB1 Chains, Humans, Male, Middle Aged, Myasthenia Gravis, Portugal, Protective Factors, Receptors, Cholinergic, Thymectomy, Thymoma, Thymus Hyperplasia, Thymus Neoplasms, Young Adult